No Data
No Data
Is China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Most readers would already be aware that China National Accord Medicines' (SZSE:000028) stock increased significantly by 13% over the past three months. Given that stock prices are usually aligned w
Private Companies Invested in China National Accord Medicines Corporation Ltd. (SZSE:000028) Copped the Brunt of Last Week's CN¥1.6b Market Cap Decline
Key Insights Significant control over China National Accord Medicines by private companies implies that the general public has more power to influence management and governance-related decisions Chi
Investors Aren't Buying China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Earnings
With a price-to-earnings (or "P/E") ratio of 9.5x China National Accord Medicines Corporation Ltd. (SZSE:000028) may be sending very bullish signals at the moment, given that almost half of all compan
Private Companies Account for 57% of China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Ownership, While Individual Investors Account for 31%
Key Insights Significant control over China National Accord Medicines by private companies implies that the general public has more power to influence management and governance-related decisions 57%
China National Accord Medicines' Profit Slides 4% in Q3
China National Accord Medicines' (SHE:000028, SHE:200028) attributable net profit fell 3.75% year over year to 359.4 million yuan in the third quarter of 2023. Earnings per share for the July to Septe
Are China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
China National Accord Medicines (SZSE:000028) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually
No Data